Amendment to At The Market Offering Agreement among Jaguar Health, Ladenburg Thalmann & Co., and Lucid Capital Markets (February 2025)
Jaguar Health, Inc., Ladenburg Thalmann & Co., Inc., and Lucid Capital Markets, LLC have agreed to extend the period during which Lucid will serve as a manager and agent under their existing At The Market Offering Agreement. Lucid's term is now extended from November 30, 2024, to June 30, 2025, unless further extended. After that date, Ladenburg will be the sole manager. Jaguar Health will reimburse Ladenburg for certain legal fees related to this amendment. All other terms of the original agreement remain unchanged.
Exhibit 10.3
February 4, 2025
Jaguar Health, Inc.
200 Pine Street, Suite 400
San Francisco, CA 94104
Attn: Lisa A. Conte, President & CEO
Dear Ms. Conte:
Reference is made to the At The Market Offering Agreement, dated as of December 10, 2021 (the “ATM Agreement”), between Jaguar Health, Inc. (the “Company”) and Ladenburg Thalmann & Co., Inc. (the “Ladenburg”), as amended by way of letter agreements dated February 2, 2022, May 23, 2024, July 17, 2024 and November 13, 2024. This letter amendment (the “Amendment”) constitutes an agreement among the Company, Ladenburg and Lucid Capital Markets, LLC (“Lucid” and together with Ladenburg, the “Managers”) to amend the ATM Agreement to confirm the extension of the term during which Lucid will continue to serve as a Manager and agent pursuant to the ATM Agreement, as more fully set forth herein. Defined terms that are used but not defined herein shall have the meanings ascribed to such terms in the ATM Agreement.
[remainder of page intentionally left blank]
In acknowledgment that the foregoing correctly sets forth the understanding reached by the parties, please sign in the space provided below, whereupon this Amendment shall constitute a binding amendment to the ATM Agreement as of the date indicated above.
Very truly yours,
LADENBURG THALMANN & CO., INC.
By: /s/ Nicholas Stergis Name: Nicholas Stergis Title: Managing Director Investment Banking
|
|
LUCID CAPITAL MARKETS, LLC
By: /s/ Vlad Ivanov Vlad Ivanov Title: Managing Director
|
|
Accepted and Agreed: JAGUAR HEALTH, INC.
By :/s/ Lisa Conte Name: Lisa Conte Title: President and CEO
|
|
[SIGNATURE PAGE TO JAGX AMENDMENT TO ATM AGREEMENT]
- 2 -